Cancer, bio-engineering, AIDS among topics at Biotech 2001 conference

July 10, 2001

BLACKSBURG, Va.-- Cancer, bio-engineered fruit, AIDS, and developing privacy policies in the wake of the mapping of the human genome are among topics that will be presented during the 6th Biotechnology 2001 Conference at Virginia Tech July 26 and 27.

Those presentations by nationally recognized experts will cap the East Coast's premier biotechnology conference for teachers. In addition to discussion of recent developments in biotechnology, the conference, which is sponsored by the university's Fralin Biotechnology Center, features hands-on workshops for high school teachers and college science professors to help them teach biotechnology concepts. The workshops are held on Thursday and Friday afternoons following the conference sessions and all day on Saturday.

Speakers scheduled for the morning of July 26 are:

- Barbara Vonderhaar, of the National Cancer Institute, who will give a presentation entitled "Prolactin: The Forgotten Hormone of Human Breast Cancer."

- Bruce Alberts, president of the National Academy of Sciences, will give a presentation entitled "Forging a New Partnership between Scientists and Science Teachers: Redefining the Scientific Community for the 21st Century."

- William Ward of Rutgers University, discussing green fluorescent protein.

Speakers scheduled for the morning of July 27 are:

- Kathy Hudson, of the National Human Genome Research Institute, who will discuss the development of policies on privacy issues for the Human Genome Project.

- Satya Dandekar, of the University of California at Davis, who will give a presentation entitled: "A Gut Feeling: Early Host-Pathogen Interactions in AIDS."

- Abhaya Dandekar, of the University of California at Davis, who will discuss bio-engineering of fruit and nut trees for quality and productivity.
Additional information about the conference is available at the Fralin Biotechnology Center's Web site ( or by calling Toby Horn at 540- 231-2692.

PR CONTACT: Stewart MacInnis

Virginia Tech

Related Cancer Articles from Brightsurf:

New blood cancer treatment works by selectively interfering with cancer cell signalling
University of Alberta scientists have identified the mechanism of action behind a new type of precision cancer drug for blood cancers that is set for human trials, according to research published in Nature Communications.

UCI researchers uncover cancer cell vulnerabilities; may lead to better cancer therapies
A new University of California, Irvine-led study reveals a protein responsible for genetic changes resulting in a variety of cancers, may also be the key to more effective, targeted cancer therapy.

Breast cancer treatment costs highest among young women with metastic cancer
In a fight for their lives, young women, age 18-44, spend double the amount of older women to survive metastatic breast cancer, according to a large statewide study by the University of North Carolina at Chapel Hill.

Cancer mortality continues steady decline, driven by progress against lung cancer
The cancer death rate declined by 29% from 1991 to 2017, including a 2.2% drop from 2016 to 2017, the largest single-year drop in cancer mortality ever reported.

Stress in cervical cancer patients associated with higher risk of cancer-specific mortality
Psychological stress was associated with a higher risk of cancer-specific mortality in women diagnosed with cervical cancer.

Cancer-sniffing dogs 97% accurate in identifying lung cancer, according to study in JAOA
The next step will be to further fractionate the samples based on chemical and physical properties, presenting them back to the dogs until the specific biomarkers for each cancer are identified.

Moffitt Cancer Center researchers identify one way T cell function may fail in cancer
Moffitt Cancer Center researchers have discovered a mechanism by which one type of immune cell, CD8+ T cells, can become dysfunctional, impeding its ability to seek and kill cancer cells.

More cancer survivors, fewer cancer specialists point to challenge in meeting care needs
An aging population, a growing number of cancer survivors, and a projected shortage of cancer care providers will result in a challenge in delivering the care for cancer survivors in the United States if systemic changes are not made.

New cancer vaccine platform a potential tool for efficacious targeted cancer therapy
Researchers at the University of Helsinki have discovered a solution in the form of a cancer vaccine platform for improving the efficacy of oncolytic viruses used in cancer treatment.

American Cancer Society outlines blueprint for cancer control in the 21st century
The American Cancer Society is outlining its vision for cancer control in the decades ahead in a series of articles that forms the basis of a national cancer control plan.

Read More: Cancer News and Cancer Current Events is a participant in the Amazon Services LLC Associates Program, an affiliate advertising program designed to provide a means for sites to earn advertising fees by advertising and linking to